- Home
- Clinical Trials
Migraine Studies Kapiti
Magnolia Migraine Study
Kapiti
Are you living with frequent migraines and interested in taking part in migraine research? Momentum Clinical Research is conducting a clinical research study evaluating an investigational oral tablet designed to help prevent migraines. By taking part, you may receive regular study-related health checks and contribute to research that could benefit others living with migraines in the future.
Description
What to expect
Study details
Ages
18-64
Duration
The study duration is up to approximately 21 weeks, with around 7 clinic visits.
Compensation
Participants will be reimbursed up to $2,380.
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 to 64 years
- Have tried between 14 preventive migraine medications that did not work
- Have not taken preventive migraine treatments in the past 3 months
- Are not currently pregnant or breastfeeding
- Are willing and able to follow all study requirements, including contraception requirements where applicable
Other criteria will apply.
Locations
Description
- Migraines are painful, debilitating neurological events often causing intense throbbing head pain, nausea, and extreme sensitivity to light and sound.
Migraines can severely disrupt daily routines, work productivity, and time spent with family. While common therapies exist, many individuals do not respond fully to them, leaving a significant need for alternative options.
This study is evaluating the safety and effectiveness of an investigational oral medication. The goal is to determine whether this treatment can successfully reduce monthly migraine days by disrupting specific inflammatory pathways involved in migraine pain.
What to expect
Participants will be randomly assigned to 1 of 3 treatment arms to receive either one of two doses of the investigational treatment or a placebo tablet.
• You will take 1 tablet in the morning and 1 tablet in the evening for 12 weeks.
• You will attend regular clinic visits for study-related health assessments, including physical exams, vital signs, heart tracings (ECGs), and blood and urine tests (including ongoing monitoring of your kidney function).
• Your safety and well-being will be closely monitored by our experienced study medical team throughout the trial.
• You will complete an electronic headache diary.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. By clicking 'Submit' you agree to our Privacy Policy which contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.